Insilico Medicine Announces 2026 Interim Earnings Conference Call Dates
CAMBRIDGE, Mass., Aug. 11, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that it will hold conference calls to discuss its financial results for the six months ended June 30, 2026 and provide a business update. The English session of the conference call will be held at 8:00...
Lifefit launches and appoints Neymar Jr. as global brand ambassador
LISBON, Portugal, Aug. 11, 2026 /PRNewswire/ -- Lifefit, a next-generation digital health platform that seamlessly integrates health, nutrition, and fitness into a single, personalized experience, today announced its global launch and unveiled Neymar Jr. as its global brand ambassador. Lifefit homepage Designed and developed in Portugal for the world, Lifefit will debut in its home market before...
Haleon and Singapore’s Agency for Science, Technology and Research (A*STAR) Launch New Clinical Study on Women’s Metabolic Health in Asia
A new clinical study on the multivitamin and mineral supplement Centrum is designed to generate evidence on metabolic health in midlife Asian women - a group often underrepresented in global nutrition research. The study will contribute to a better understanding of preventive healthcare and healthy ageing in Asian populations. ...
Global Study Results Published in Aesthetic Surgery Journal Open Forum Show Link Between Self-Confidence and Aesthetics
Publication in the peer-reviewed journal reinforces the study's insights and validates what clinicians frequently observe – that the impact of aesthetic treatments extends beyond physical appearance. The Pillars of Confidence Global Study, supported by Merz Aesthetics, evaluated the impact of aesthetic treatments on patient confidence Study findings validate what...
Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery
LAGUNA HILLS, Calif. and SHANGHAI, Aug. 11, 2026 /PRNewswire/ -- Aureka Biotechnologies announced the close of a US$100 million Series B financing on Aug. 10, 2026. Granite Asia funded the first tranche exclusively, and a prominent strategic investor led a subsequent tranche, with participation from HighLight Capital (HLC) and follow-on investment from existing shareholders including MPCi and NRL Capital....
Hong Kong’s Biotech Edge Unveiled Through BIOHK: The Super-Connector and Value-Adder Bridging Global Science and Capital
HONG KONG, Aug. 10, 2026 /PRNewswire/ -- Per BIOHK2025 official briefing materials, a Swiss cell therapy biotech founder scans the bustling conference floor of BIOHK2025, shaking hands with Nobel laureates, Hong Kong financial regulators, mainland biotech lab directors and Asia-focused venture capitalists all within a single day. For decades, his firm chased dual goals: breaking into China's vast...
Lifespan Vision Ventures Leads Remedium Bio’s Series A Financing
Investment supports advancement of Remedium's durable protein therapeutics platform toward first-in-human clinical development. NORWALK, Conn., Aug. 10, 2026 /PRNewswire/ -- Lifespan Vision Ventures today announced that it is leading Remedium Bio, Inc.'s ("Remedium") $10 million Series A financing and has completed the round's initial closing, with participation from Eli Lilly and...
Unveiling a Smarter Future for Dentistry at China Dental Show 2026
AI-powered clinical solutions, hands-on experiences and global business opportunities will come together in Shanghai from October 13 to 16 SHANGHAI, Aug. 10, 2026 /PRNewswire/ -- China Dental Show 2026 (CDS 2026) will take place from October 13 to 16 at the National Exhibition and Convention Center (Shanghai), bringing together dental professionals, distributors and buyers from around the world...
NYSE Content Update: Goldman Sachs Asset Management Launches Two New ETFs
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 10, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. LifeMine raises $263 million in...
POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine
GUANGZHOU, China, Aug. 10, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today highlighted its healthcare intelligence flywheel, a closed-loop growth model that integrates AI, wearable devices, healthcare data, professional medical services, and insurance payment networks. The Company believes this model enables...
